These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. Summers JB, Kim KH, Mazdiyasni H, Holms JH, Ratajczyk JD, Stewart AO, Dyer RD, Carter GW. J Med Chem; 1990 Mar; 33(3):992-8. PubMed ID: 2308149 [Abstract] [Full Text] [Related]
3. In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase. Summers JB, Gunn BP, Mazdiyasni H, Goetze AM, Young PR, Bouska JB, Dyer RD, Brooks DW, Carter GW. J Med Chem; 1987 Nov; 30(11):2121-6. PubMed ID: 3669019 [Abstract] [Full Text] [Related]
4. Synthesis and 5-lipoxygenase inhibitory activity of 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid analogues. Kerdesky FA, Schmidt SP, Holms JH, Dyer RD, Carter GW, Brooks DW. J Med Chem; 1987 Jul; 30(7):1177-86. PubMed ID: 3599023 [Abstract] [Full Text] [Related]
5. Quantitative structure-activity relationship study on some 5-lipoxygenase inhibitors. Gupta SP, Gupta JK. J Enzyme Inhib; 1990 Jul; 3(3):179-88. PubMed ID: 2079634 [Abstract] [Full Text] [Related]
6. Antioxidant and anti-inflammatory activity of aryl-acetic and hydroxamic acids as novel lipoxygenase inhibitors. Pontiki E, Hadjipavlou-Litina D. Med Chem; 2006 May; 2(3):251-64. PubMed ID: 16948471 [Abstract] [Full Text] [Related]
7. Acetohydroxamic acids as potent, selective, orally active 5-lipoxygenase inhibitors. Jackson WP, Islip PJ, Kneen G, Pugh A, Wates PJ. J Med Chem; 1988 Mar; 31(3):499-500. PubMed ID: 3346867 [No Abstract] [Full Text] [Related]
8. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses. Bhattacherjee P, Boughton-Smith NK, Follenfant RL, Garland LG, Higgs GA, Hodson HF, Islip PJ, Jackson WP, Moncada S, Payne AN. Ann N Y Acad Sci; 1988 Mar; 524():307-20. PubMed ID: 2837965 [Abstract] [Full Text] [Related]
9. Nonsteroidal antiinflammatory drug hydroxamic acids. Dual inhibitors of both cyclooxygenase and 5-lipoxygenase. Flynn DL, Capiris T, Cetenko WJ, Connor DT, Dyer RD, Kostlan CR, Nies DE, Schrier DJ, Sircar JC. J Med Chem; 1990 Aug; 33(8):2070-2. PubMed ID: 2115586 [No Abstract] [Full Text] [Related]
10. Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors. Phillips OA, Bosso MA, Ezeamuzie CI. J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1471-1482. PubMed ID: 32635785 [Abstract] [Full Text] [Related]
11. Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis. Summers JB, Gunn BP, Martin JG, Martin MB, Mazdiyasni H, Stewart AO, Young PR, Bouska JB, Goetze AM, Dyer RD. J Med Chem; 1988 Oct; 31(10):1960-4. PubMed ID: 3172130 [Abstract] [Full Text] [Related]
12. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Tateson JE, Randall RW, Reynolds CH, Jackson WP, Bhattacherjee P, Salmon JA, Garland LG. Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160 [Abstract] [Full Text] [Related]
13. 2-substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity. Batt DG, Maynard GD, Petraitis JJ, Shaw JE, Galbraith W, Harris RR. J Med Chem; 1990 Jan; 33(1):360-70. PubMed ID: 2104936 [Abstract] [Full Text] [Related]
14. Novel bishydroxamic acids as 5-lipoxygenase inhibitors. Ohemeng KA, Nguyen VN, Schwender CF, Singer M, Steber M, Ansell J, Hageman W. Bioorg Med Chem; 1994 Mar; 2(3):187-93. PubMed ID: 7922131 [Abstract] [Full Text] [Related]
15. Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis. Huang FC, Shoupe TS, Lin CJ, Lee TD, Chan WK, Tan J, Schnapper M, Suh JT, Gordon RJ, Sonnino PA. J Med Chem; 1989 Aug; 32(8):1836-42. PubMed ID: 2502629 [Abstract] [Full Text] [Related]
16. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity. Hamer RR, Tegeler JJ, Kurtz ES, Allen RC, Bailey SC, Elliott ME, Hellyer L, Helsley GC, Przekop P, Freed BS, White J, Martin LL. J Med Chem; 1996 Jan 05; 39(1):246-52. PubMed ID: 8568814 [Abstract] [Full Text] [Related]
17. Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxyeicosa-5,8,11,13-tetraenoic acid analogues. Haviv F, Ratajczyk JD, DeNet RW, Martin YC, Dyer RD, Carter GW. J Med Chem; 1987 Feb 05; 30(2):254-63. PubMed ID: 3806609 [Abstract] [Full Text] [Related]
18. 1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity. Mylari BL, Carty TJ, Moore PF, Zembrowski WJ. J Med Chem; 1990 Jul 05; 33(7):2019-24. PubMed ID: 2113951 [Abstract] [Full Text] [Related]
19. Immunoregulatory properties of novel specific inhibitors of 5-lipoxygenase. Liu DS, Liew FY, Rhodes J. Immunopharmacology; 1989 Jul 05; 17(1):1-9. PubMed ID: 2540117 [Abstract] [Full Text] [Related]
20. Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes. Hanko R, Hammond MD, Fruchtmann R, Pfitzner J, Place GA. J Med Chem; 1990 Apr 05; 33(4):1163-70. PubMed ID: 2319562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]